3rd Quarter - Report
NOVAVAX, INC for NOVAVAX, INC
Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES CAMPOLONGO New | — |
| KELLY CAPPIO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.